A61K 39/17
Newcastle disease virus
A61K39/17 (Newcastle disease virus) appears on 141 US grants and 165 published applications in this corpus.
Search patents in A61K- Granted patents
- 141
- Published applications
- 165
- Assignees
- 93
- Inventors
- 333
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 2 |
| 2003 | 4 | 3 |
| 2004 | 4 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 2 |
| 2007 | 2 | 5 |
| 2008 | 0 | 0 |
| 2009 | 4 | 6 |
| 2010 | 1 | 10 |
| 2011 | 4 | 3 |
| 2012 | 3 | 8 |
| 2013 | 1 | 3 |
| 2014 | 5 | 16 |
| 2015 | 7 | 6 |
| 2016 | 12 | 13 |
| 2017 | 10 | 11 |
| 2018 | 6 | 13 |
| 2019 | 17 | 7 |
| 2020 | 5 | 7 |
| 2021 | 3 | 10 |
| 2022 | 6 | 12 |
| 2023 | 2 | 5 |
| 2024 | 7 | 9 |
| 2025 | 5 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of beta-glucan extract in the immunopotentiation of an avian animal28 Apr 2026US 12,611,420 B2Lesaffre Et Compagnie
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)14 Oct 2025US 12,440,552 B2University of Massachusetts
- Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same5 Mar 2026US 2026/0061047 A1Biopoa, Inc.
- Bi-specific targeted chimeric antigen receptor t cells15 Jan 2026US 2026/0015404 A1City of Hope
- Vaccine against infectious bronchitis25 Sep 2025US 2025/0295752 A1Zoetis Services LLC
- Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens25 Sep 2025US 2025/0295753 A1Edge Animal Health, Inc.
- Multivalent kaposi sarcoma-associated herpesvirus-like particles and uses thereof22 May 2025US 2025/0161435 A1City of Hope
Most cited
By later US patents
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004
- Newcastle disease virus combination vaccine59US 5,733,556 AAkzo Nobel N. V. · 1998
- Recombinant poxvirus compositions and methods of inducing immune responses55US 5,942,235 AHealth Research, Inc. · 1999